Harprit Singh: Future – Ready Hospitals Will Have Apheresis Hubs, Not Just Dialysis Units
Harprit Singh, Associate Director at Transfusion Technologies, Therapies, Solutions and Consultant in Transfusion Medicine at Alchemist Hospital, shared a post on LinkedIn:
“Future – Ready Hospitals Will Have Apheresis Hubs – Not Just Dialysis Units
Most hospitals don’t have an apheresis problem.
They have a utilization problem.
In multiple institutions I’ve worked with, the pattern is consistent:
- Apheresis machines exist.
- Clinical expertise exists.
- But activation pathways don’t.
The result?
- Delayed therapeutic plasma exchange (TPE)
- Underutilized apheresis services
- Missed integration with solid organ and bone marrow transplant (BMT) and oncology
- Higher ICU burden and avoidable costs
This is where strategy changes everything.
Hospitals that build Clinical Apheresis Hubs – not fragmented services – unlock the following:
- Faster intervention in critical care
- Seamless transplant and cellular therapy workflows
- Reduced ICU dependency
High-value, predictable clinical revenue
Because an Apheresis Hub is not equipment.
It is a clinical plus operational plus financial system.
Protocols define speed
Ownership defines utilisation.
The question is no longer:
‘Do we have apheresis?’
It is:
‘Is it integrated into how we deliver care?’
For COs and administrators, this is where transfusion medicine becomes strategy – not support.
A practical starting point:
Map 3 things
Who triggers apheresis?
How fast can it be activated?
How often is iused?
An open question:
What is the single biggest barrier to apheresis utilisation in your institution today?”
Stay updated with Hemostasis Today.
-
Jun 3, 2026, 04:12Lynne Baird: Why Bleed Control Kits Belong in Every Public Space
-
Jun 2, 2026, 19:42Sékouba Sidimé: vWD vs Hemophilia A – The Classic USMLE Step 1 trap in Hematology
-
Jun 2, 2026, 19:41Bassem M. Mohammed: How Factor VIII Interacts To Procoagulant Membranes To Support Activation Of Blood Clotting
-
Jun 2, 2026, 19:28Looking Beyond Bleeding Control To Understand Inflammation In Hemophilic Arthropathy – CRH French Reference Center for Hemophilia Lyon
-
Jun 2, 2026, 19:27Francisco Chacón-Lozsán: Coma Is Not a Diagnosis – Final Pathway Of Brain Arousal And Awareness Failure
-
Jun 2, 2026, 19:26Panagiotis Papanagiotou: Recognizing CVST On T2 MRI
-
Jun 2, 2026, 17:56Coralie Delporte Gravouil: Scientific Program 2026 – Essentials of Hemostasis Now Available
-
Jun 2, 2026, 17:55Anna Rivera: Hemophilia Management – A Shift from Traditional IV Therapies to Novel Subcutaneous Agents
-
Jun 2, 2026, 17:53Zoya Surayya: My Thesis on Anticoagulation After Ischemic Stroke